try platform based on the Enzyme-Linked Immuno-Sorbent Assay (ELISA) biochemical technique. For food safety testing, Searchlight is capable of detecting toxins including E. coli, salmonella, listeria and campylobacter. According to the Centers for Disease Control and Prevention (CDC), about 48 million people (1 in 6 Americans) get sick, 128,000 are hospitalized, and 3,000 die each year from foodborne diseases.
"As we bring strategic partners on board, both CapWave and the Searchlight device come into greater focus," Ellsworth said. "As I share our story at AOAC, I believe the industry will be intrigued by this device. More sensitivity, more speed, smaller sample sizes, it's an elegant solution."
The Searchlight™ device will first be available for food safety testing. Product development for the veterinary and in vitro diagnostic markets is also being evaluated.
To set up a meeting with SUTIMCo at AOAC, please contact Boost Marketing at (407) 389-5900
For more information on CapWave Sensors, please visit; http://www.capwavesensors.com
For more information on SUTIMCo, its portfolio companies, and university partners, please visit; http://www.suti.com
About SUTIMCo International, Inc.:
SUTIMCo International Inc. is a holding company, which utilizes a unique and established platform to launch new technology enterprises based on world-class university research discoveries. SUTIMCo International through its wholly owned subsidiary SUTIMCo, Inc., provides experienced management to early stage companies, reducing risk and assuring the know-how in launching and growing a new company. In addition to this skilled management team, SUTIMCo can avail itself of the encyclopedic, informal knowledge of the inventor, his experience and his research team.
Safe Harbor: Statements regarding financial matters in this
Page: 1 2 3 Related medicine technology :1
|SOURCE SUTIMCo International, Inc.|
Copyright©2010 PR Newswire.
All rights reserved
. New International Pharmaceutical Company Pro Bono Bio Launched Today2
. Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force3
. VWR International, LLC Acquires INTERNATIONAL P.B.I. S.p.A.4
. Bench International Expands Presence in Europe with Opening of Offices in Switzerland5
. Bacterin International to Present at Rodman & Renshaw Annual Global Investment Conference on September 12, 20116
. Spaulding Clinical Announces Strategic Partnership with Clinigene International, India for Providing Comprehensive Early Clinical Solutions to Pharmaceutical and Biotech Clients7
. Chindex International, Inc. Announces Participation in Upcoming Investor Conferences8
. Pharmaceutics International, Inc. (Pii) Successfully Completes EMA and FDA Inspection9
. Urgent® PC Clinical Studies Results Scheduled for Presentation at International Continence Society10
. International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment11
. PAREXEL International Reports Fourth Quarter and Fiscal Year 2011 Results